GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Marketable Securities

IXSBF (InNexus Biotechnology) Marketable Securities : $0.00 Mil (As of Mar. 2011)


View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. InNexus Biotechnology's Marketable Securities for the quarter that ended in Mar. 2011 was $0.00 Mil.


InNexus Biotechnology Marketable Securities Historical Data

The historical data trend for InNexus Biotechnology's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Marketable Securities Chart

InNexus Biotechnology Annual Data
Trend Jun01 Jun02 Jun03 Jun04 Jun05 Jun06 Jun07 Jun08 Jun09 Jun10
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

InNexus Biotechnology Quarterly Data
Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

InNexus Biotechnology Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


InNexus Biotechnology  (GREY:IXSBF) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".


InNexus Biotechnology Marketable Securities Related Terms

Thank you for viewing the detailed overview of InNexus Biotechnology's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


InNexus Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7
InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology Headlines

No Headlines